Virtu Financial LLC Invitae Corp Transaction History

Virtu Financial LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$1.2 - $2.73 $273,783 - $622,857	228,153 New	228,153 $308,000
Q3 2022 Nov 07, 2022	SELL	$1.9 - $8.63 $59,772 - $271,491	-31,459 Reduced 61.92%	19,346 $48,000
Q2 2022 Aug 09, 2022	BUY	$2.13 - $9.01 $108,214 - $457,753	50,805 New	50,805 $124,000
Q4 2021 Feb 17, 2022	SELL	$14.7 - $28.67 $546,604 - $1.07 Million	-37,184 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $903,943 - $1.25 Million	37,184 New	37,184 $1.06 Million
Q2 2021 Sep 17, 2021	SELL	$26.09 - $40.4 $1.56 Million - $2.41 Million	-59,612 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$33.06 - $56.93 $228,543 - $393,557	6,913 Added 13.12%	59,612 $2.28 Million
Q4 2020 Feb 24, 2021	BUY	$39.09 - $57.4 $509,850 - $748,668	13,043 Added 32.89%	52,699 $2.2 Million
Q3 2020 Dec 11, 2020	BUY	$28.43 - $44.67 $1.13 Million - $1.77 Million	39,656 New	39,656 $1.72 Million
Q4 2019 Feb 04, 2020	SELL	$15.02 - $20.57 $226,186 - $309,763	-15,059 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$18.85 - $27.5 $283,862 - $414,122	15,059 New	15,059 $290,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.